Skip to main content
logo
Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.710
-0.890 (-34.23%)
At close: Sep 3, 2026, 4:00 PM EDT
1.643
-0.067 (-3.89%)
Pre-market: Sep 4, 2026, 6:41 AM EDT

Aptevo Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.821.628.7116.922.6445.04
Cash & Short-Term Investments
9.821.628.7116.922.6445.04
Cash Growth
4.11%148.09%-48.45%-25.32%-49.75%12.67%
Accounts Receivable
----2.53.66
Receivables
----2.53.66
Prepaid Expenses
0.540.610.931.471.571.82
Restricted Cash
-----1.26
Other Current Assets
0.460.851.020.690.740.78
Total Current Assets
10.823.0810.6619.0727.4552.57
Property, Plant & Equipment
3.724.114.935.786.773.96
Other Long-Term Assets
0----0.07
Total Assets
14.5227.1915.5924.8434.2256.6

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.160.881.243.983.53.46
Accrued Expenses
3.114.314.22.12.112.08
Current Portion of Long-Term Debt
----211.67
Current Portion of Leases
0.920.870.77-0.42-
Current Unearned Revenue
-----15.47
Other Current Liabilities
---1.140.682.09
Total Current Liabilities
5.196.056.217.228.7134.76
Long-Term Debt
----1.463.71
Long-Term Leases
3.293.764.635.46.081.34
Long-Term Unearned Revenue
-----15.58
Total Liabilities
8.489.8110.8412.6216.2455.39

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.110.110.080.060.050.05
Additional Paid-In Capital
294.19292.38252.25235.61223.96215.23
Retained Earnings
-288.26-275.12-247.58-223.45-206.04-214.06
Shareholders' Equity
6.0417.384.7612.2217.971.22
Total Liabilities & Equity
14.5227.1915.5924.8434.2256.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4.214.635.45.49.9616.72
Net Cash (Debt)
5.5916.993.3211.5112.6828.33
Net Cash Growth
26.97%412.21%-71.17%-9.24%-55.24%125.46%
Net Cash Per Share
6.2753.85----
Filing Date Shares Outstanding
1.81.18----
Total Common Shares Outstanding
1.421----
Working Capital
5.6117.034.4511.8418.7417.81
Book Value Per Share
4.2617.42----
Tangible Book Value
6.0417.384.7612.2217.971.22
Tangible Book Value Per Share
4.2617.42----
Machinery
-12.2212.2612.2612.2612.43
Leasehold Improvements
-2.232.232.232.232.23
SEC Filings: 10-K · 10-Q